TherapeuticsMD, Inc. — Director's Dealing 2015

Feb 18, 2015

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-12-31

Reporting Person: Finizio Robert G (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-11	Common Stock	G	145000	$0.00	Disposed	18916059	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000000	Indirect

Footnotes

F1: By grantor-retained annuity trust ("GRAT"). Previously reported as directly held by reporting person.